Robert Patrick Giugliano
Impact in
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.02%
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
Papers in
-
- Atrial Fibrillation Management and Outcomes 155
- Acute Myocardial Infarction Research 142
- Antiplatelet Therapy and Cardiovascular Diseases 50
- Cardiac Arrhythmias and Treatments 29
- Surgery 178
- Lipoproteins and Cardiovascular Health 122
- Coronary Interventions and Diagnostics 38
- Co-authors
- Marc Steven Sabatine (129 shared papers)Sabina A. Murphy (134 shared papers)Eugene Braunwald (134 shared papers)Elliott Marshall Antman (149 shared papers)Christian Thomas Ruff (117 shared papers)ANTHONY C. KEECH (43 shared papers)Scott M. Wasserman (28 shared papers)Terje Rolf Pedersen (27 shared papers)
- Journals
- Journal of the American College of Cardiology (115 papers)Circulation (59 papers)European Heart Journal (38 papers)American Heart Journal (38 papers)The American Journal of Cardiology (32 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert Patrick Giugliano
562 papers receiving 46.5k citations
Robert Patrick Giugliano's Hit Papers
Peers
Comparison fields: 5 of 173
- Internal Medicine 4.4k
- Cardiology and Cardiovascular Medicine 22.3k
- Surgery 18.7k
- Endocrinology, Diabetes and Metabolism 5.0k
- Cancer Research 2.1k
Countries citing papers authored by Robert Patrick Giugliano
This map shows the geographic impact of Robert Patrick Giugliano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Patrick Giugliano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Patrick Giugliano more than expected).
Fields of papers citing papers by Robert Patrick Giugliano
This network shows the impact of papers produced by Robert Patrick Giugliano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Patrick Giugliano. The network helps show where Robert Patrick Giugliano may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Patrick Giugliano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 588 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease Hit paper breakdown → | 2017 | 4576 |
| 2 | Edoxaban versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2013 | 4098 |
| 3 | Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Hit paper breakdown → | 2013 | 3869 |
| 4 | Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes Hit paper breakdown → | 2015 | 3434 |
| 5 | Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events Hit paper breakdown → | 2015 | 1251 |
| 6 | TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation Hit paper breakdown → | 2000 | 1241 |
| 7 | Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions Hit paper breakdown → | 2016 | 1168 |
| 8 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 727 |
| 9 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 612 |
| 10 | Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes Hit paper breakdown → | 2005 | 596 |
| 11 | Variation inPCSK9andHMGCRand Risk of Cardiovascular Disease and Diabetes Hit paper breakdown → | 2016 | 594 |
| 12 | Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial Hit paper breakdown → | 2017 | 545 |
| 13 | 1999 | 538 | |
| 14 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 485 |
| 15 | 2010 | 393 | |
| 16 | Cognitive Function in a Randomized Trial of Evolocumab Hit paper breakdown → | 2017 | 387 |
| 17 | 2009 | 381 | |
| 18 | Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study Hit paper breakdown → | 2012 | 376 |
| 19 | Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial Hit paper breakdown → | 2015 | 337 |
| 20 | Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Hit paper breakdown → | 2017 | 332 |
About Robert Patrick Giugliano
Robert Patrick Giugliano is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 588 papers that have together received 48.8k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (155 papers), Acute Myocardial Infarction Research (142 papers), Lipoproteins and Cardiovascular Health (122 papers), Antiplatelet Therapy and Cardiovascular Diseases (50 papers), Venous Thromboembolism Diagnosis and Management (47 papers), Cardiac Imaging and Diagnostics (41 papers), Coronary Interventions and Diagnostics (38 papers) and Cardiac Arrhythmias and Treatments (29 papers). The work is most often cited by research in Internal Medicine (4.4k citations), Cardiology and Cardiovascular Medicine (22.3k citations), Surgery (18.7k citations), Endocrinology, Diabetes and Metabolism (5.0k citations) and Cancer Research (2.1k citations). Robert Patrick Giugliano has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc Steven Sabatine, Sabina A. Murphy, Eugene Braunwald, Elliott Marshall Antman, Christian Thomas Ruff, ANTHONY C. KEECH, Scott M. Wasserman, Terje Rolf Pedersen, Stephen D. Wiviott and Julia Kuder. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, European Heart Journal, American Heart Journal and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.